Effect of simvastatin on burn-induced alterations in tissue specific glucose metabolism: Implications for burn associated insulin resistance

International Journal of Molecular Medicine

Volumn 26, Issue 3, 2010, Pages 311-316

  Bonab, Ali A ^a,b   Carter, Edward A ^a,b   Paul, Kasie ^b   Kaneki, Masao ^a,b   Yu, Yong Ming ^a,b   Tompkins, Ronald G ^a,b   Fischman, Alan J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

18F labeled 2 fluoro 2 deoxy D glucose; Brown adipose tissue; Burn; Glucose; Insulin resistance; Sepsis; Simvastatin

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HYPOCHOLESTEROLEMIC AGENT; RADIOPHARMACEUTICAL AGENT; SIMVASTATIN;

ADIPOSE TISSUE; ANIMAL; BRAIN; BURN; GLUCOSE TOLERANCE TEST; HEART MUSCLE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; RAT; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ANIMALS; ANTICHOLESTEREMIC AGENTS; BRAIN; BURNS; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MICE; MYOCARDIUM; RADIOPHARMACEUTICALS; RATS; SIMVASTATIN; TISSUE DISTRIBUTION;

EID: 77956704545     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000467     Document Type: Article

References (20)

1. Carter E, Tompkins RG, Babich JW and Fischman AJ: Effect of thermal injury on uptake and phosphorylation of F-18 flurodeoxyglucose. J Nucl Med 34: P175, 1994.
2. Carter EA, Tompkins RG, Babich JW, Correia JA and Fischman AJ: Effects of thermal injury and modifiers of energy metabolism on FDG utilization by rat brain. J Nucl Med 36: P205, 1995.
3. Carter EA, Tompkins RG, Babich JW, Correia J and Fischman AJ: Decreased cerebral glucose utilization in rats during the ebb phase of thermal injury. J Trauma 40: 930-935, 1996. (Pubitemid 26179383)
4. Zhang Q, Carter EA, Ma B, Fischman AJ and Tompkins RG: Burn-related metabolic and signaling changes in rat brain. J Burn Care Res 29: 346-352, 2008. (Pubitemid 351498830)
5. Carter EA, Winter D, Tolman C, Tompkins RG and Fischman AJ: Burn induced changes in cerebral and myocardial glucose metabolism in rodents. J Nucl Med 50: P1216, 2009.
6. Chaudry MZ, Want JH, Blankson S and Redmond HP: Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg Infect 9: 183-194, 2008. (Pubitemid 351563813)
7. Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM: Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy 29: 621-630, 2009.
8. Fogerty MD, Abumrad N, Efron D, Guy J and Barbul A: The effect of preinjury statin use on mortality and sepsis in elderly burn patients. J Trauma (In press).
9. Beffa DC, Carter EA, Hamrahi VF, Yu YM, Fagan S, Sheridan RL, Fischman AJ and Tompkins RG: Simvastatin improves survival in murine gram negative burn sepsis. J Burn Care Res 28: S85, 2007.
10. Shinozaki S, Inoue Y, Yang W, Fukaya M, Carter EA, Yu YM, Fischman AJ, Tompkins RG and Kaneki M: Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice. Biochem Biophys Res Commun 391: 1459-1464, 2010.
11. Zhang Q, Carter EA, Ma BY, White M, Fischman AJ and Tompkins RG: Molecular mechanism(s) of burn induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Science 77: 3068-3077, 2005. (Pubitemid 41430280)
12. Carter EA, Burks D, Fischman AJ, White M and Tompkins RG: Insulin resistance in thermally injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int J Mol Med 14: 653-658, 2004.
13. Tai C, Chatziioannou A, Siegel S, Young J, Newport D, Goble RN, Nutt RE and Cherry SR: Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol 46: 1845-1862, 2001.
14. Guclu F, Ozmen B, Hekimsoy Z and Kirmaz C: Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome. Biomed Pharmacother 58: 614-618, 2004. (Pubitemid 40260386)
15. Lalli CA, Pauli JR, Prada PO, Cintra DE, Ropelle ER, Velloso LA and Saad MJ: Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet. Metabolism 57: 57-65, 2009.
16. Naples M, Federico LM, Xu E, Nelken J and Adeli K: Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization. Atherosclerosis 198: 94-103, 2008.
17. Abe M, Matsuda M, Kobayashi H, Miyata Y, Nakayama Y, Komuro R, Fukuhara A and Shimomura I: Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-β pathway in macrophages. Atherioscler Thromb Vasc Biol 28: 871-877, 2008.
18. Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell, ME Apovian CM, Freedman J and Gokce N: Inducible toll-like receptor and NF-?B regulatory pathway expression in human adipose tissue. Obesity 16: 932-937, 2008.
19. Zelvyte I, Dominaitiene R, Crisby M and Janciauskiene S: Modulation of inflammatory mediators and PPAR gamma and NF kappa B expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol Res 45: 147-154, 2002. (Pubitemid 35425654)
20. Giusti-Paiva A, Martinez MR, Felix JV, da Rocha MJ, Carnio EC, Elias LL and Antunes-Rodrigues J: Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats. Shock 21: 271-275, 2004.